600332 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Closed 03-21 15:00:00
26.60
-0.06
-0.23%
| High26.95 | Low26.56 | Vol10.39M |
| Open26.80 | D1 Closing26.66 | Amplitude1.46% |
| Mkt Cap43.25B | Tradable Cap37.40B | Total Shares1.63B |
| T/O278.00M | T/O Rate0.74% | Tradable Shares1.41B |
| P/B1.2 | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
暂无数据
Baiyunshan Pharmaceutical Gets Nod to Outsource Ginger Granule Production
MT Newswires Live · 03-18
Guangzhou Baiyunshan Pharmaceutical Plans to Apply for Credit Line
MT Newswires Live · 03-14
Baiyunshan Pharmaceutical 2024 Profit Down 30%, Revenue Slips 0.7%
MT Newswires Live · 03-14
Baiyunshan Pharmaceutical Says 2024 Net Profit Down 30.1% Y/Y
THOMSON REUTERS · 03-13
BRIEF-Baiyunshan Pharmaceutical's 2024 Net Profit Down 30.1% Y/Y
Reuters · 03-13
Baiyunshan Pharmaceutical's Branch Gets Nod to Market Atorvastatin Calcium
MT Newswires Live · 03-07
DIARY-China corporate earnings week ahead
Reuters · 03-07
Baiyunshan Pharma's Unit Gets Regulatory Nod to Amend License
MT Newswires Live · 03-06
Guangzhou Baiyunshan Pharmaceutical - Disposal of Second New Underlying Assets of Gp Corp. to Industrial Securities Asset Management for RMB583.1 Mln
THOMSON REUTERS · 02-28
MORNING BID ASIA-Tariffs, tech fatigue rev up month-end turbulence
Reuters · 02-27
BRIEF-Guangzhou Baiyunshan Pharmaceutical Received Written Resignation From Executive Director
Reuters · 02-14
Guangzhou Baiyunshan Pharmaceutical - Received Written Resignation From Wu Changhai as Executive Director
THOMSON REUTERS · 02-14
Baiyunshan Pharmaceutical Gets Regulatory Approval to Amend Drug Production License
MT Newswires Live · 02-13
Guangzhou Baiyunshan Pharmaceutical Passes Generic Drug Evaluation for Antibiotic Drug
MT Newswires Live · 01-24
BRIEF-Guangzhou Baiyunshan Pharmaceutical Says Liu Juyan Resigns As Executive Director Of 9th Session
Reuters · 01-21
Guangzhou Baiyunshan Pharmaceutical - Received Resignation From Liu Juyan as Executive Director of 9TH Session
THOMSON REUTERS · 01-21
BRIEF-Guangzhou Baiyunshan Pharmaceutical Elects Chairman
Reuters · 01-21
Guangzhou Baiyunshan Pharmaceutical Says Board Agrees to Elect Li Xiaojun as Chairman
THOMSON REUTERS · 01-21
Guangzhou Baiyunshan Pharma Gets Local Approval to Reduce, Add Production Lines
MT Newswires Live · 01-16
Baiyunshan Pharma's Venture Capital Fund Completes Registration
MT Newswires Live · 01-08
Introduction
Company Name.
广州白云山医药集团股份有限公司
Industry:
医药制造业
Listing Date:
2001-02-06
Main Business:
广州白云山医药集团股份有限公司的主营业务是中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研发、制造与销售；西药、中药和医疗器械的批发、零售和进出口业务；大健康产品的研发、生产与销售；医疗服务、健康管理、养生养老等健康产业投资。公司的主要产品是中成药、化学药。本集团及合营企业共获得国家科技进步奖1项，省级科技进步奖3项，其中白云山和黄公司“中药质量检测技术集成创新与支撑体系创建及应用”荣获“国家科学技术进步奖”。
Issue price:
9.80
Invest in Global Markets with Tiger Brokers!Open App